[1] TEFFERI A,VARDIMAN JW.Myelodysplastic syndromes[J].N Engl J Med,2009,361(19):1872-1885.
[2] HARHAJI-TRAJKOVIC L,VILIMANOVICH U,KRAVIC-STEVOVIC T,et al.AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells[J].J Cell Mol Med,2009,13(9B):3644-3654.
[3] KIM YC,GUAN KL.mTOR:a pharmacologic target for autophagy regulation[J].J Clin Invest,2015,125(1):25-32.
[4] LEVY JMM,TOWERS CG,THORBURN A.Targeting autophagy in cancer[J].Nat Rev Cancer,2017,17(9):528-542.
[5] KIM TW,CHEON C,KO SG.SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells[J].Cell Death Dis,2020,11(8):717.
[6] RUSSO M,RUSSO GL.Autophagy inducers in cancer[J].Biochem Pharmacol,2018,153:51-61.
[7] LI X,HE S,MA B.Autophagy and autophagy-related proteins in cancer[J].Mol Cancer,2020,19(1):12.
[8] 岳青芳.mTORC2/mTORC1抑制剂诱导骨髓增生异常综合征/急性白血病细胞发生自噬性死亡及作用机制研究[D].武汉:华中科技大学,2015.
YUE QF.Dual mTORC2/mTORC1 inhibitor induces autophagic cell death of MDS/AML and its underlying mechanism[D].Wuhan:Huazhong University of Science and Technology,2015.
[9] YANG G,MURASHIGE DS,HUMPHREY SJ,et al.A positive feedback loop between Akt and mTORC2 via SIN1 phosphorylation[J].Cell Rep,2015,12(6):937-943.
[10] JHANWAR-UNIYAL M,WAINWRIGHT JV,MOHAN AL,et al.Diverse signaling mechanisms of mTOR complexes:mTORC1 and mTORC2 in forming a formidable relationship[J].Adv Biol Regul,2019,72:51-62.
[11] SABATINI DM.mTOR and cancer:insights into a complex relationship[J].Nature Reviews Cancer,2006,6(9):729-734.
[12] JUNG M,CHOI H,MUN JY.The autophagy research in electron microscopy[J].Appl Microsc,2019,49(1):11.
[13] KROEMER G,GALLUZZI L,VANDENABEELE P,et al.Classification of cell death:recommendations of the Nomenclature Committee on Cell Death 2009[J].Cell Death Differ,2009,16(1):3-11.
[14] WU J,DANG Y,SU W,et al.Molecular cloning and characterization of rat LC3A and LC3B-two novel markers of autophagosome[J].Biochem Biophys Res Commun,2006,339(1):437-442.
[15] WHITE E.The role for autophagy in cancer[J].J Clin Invest,2015,125(1):42-46.
[16] KROEMER G,LEVINE B.Autophagic cell death:the story of a misnomer[J].Nat Rev Mol Cell Biol,2008,9(12):1004-1010.
[17] KOCATURK NM,AKKOC Y,KIG C,et al.Autophagy as a molecular target for cancer treatment[J].Eur J Pharm Sci,2019,134:116-137.
[18] YOSHIDA GJ.Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death:from pathophysiology to treatment[J].J Hematol Oncol,2017,10(1):67.
[19] WAETZIG R,MATTHES M,LEISTER J,et al.Comparing mTOR inhibitor Rapamycin with Torin-2 within the RIST molecular-targeted regimen in neuroblastoma cells[J].Int J Med Sci,2021,18(1):137-149.
[20] BU H,TAN S,YUAN B,et al.Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling[J].Mol Ther Oncolytics,2021,20:82-93.
[21] NAZIO F,BORDI M,CIANFANELLI V,et al.Autophagy and cancer stem cells:molecular mechanisms and therapeutic applications[J].Cell Death Differ,2019,26(4):690-702.